Rare diseases
Investigational molecules
Locations
120 Saint James Avenue, 02116-5001, United States
Eip Pharma Inc. focuses on clinical research in dementia with Lewy bodies, a neurodegenerative disorder marked by cognitive decline and associated neurological symptoms. Its studies are centered on patients with probable DLB and use clinical measures relevant to disease severity and functional change.
The sponsor’s trial activity is directed toward understanding treatment effects in an age-defined DLB population across active research sites in North America and Europe.
Eip Pharma Inc. runs clinical trials in conditions such as Dementia with Lewy bodies, Dementia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
France
The NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
